How to manage aspergillosis in non-neutropenic intensive care unit patients

Massimo Antonelli, Matteo Bassetti, Elda Righi, Raffaele De Gaudio, Antonino Giarratano, Tereesita Mazzei, Giulia Morace, Nicola Petrosillo, Stefania Stefani

Risultato della ricerca: Contributo in rivistaArticolo in rivista

29 Citazioni (Scopus)

Abstract

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level of suspicion and prompt initiation of adequate antifungal treatment are mandatory. Epidemiology, risk factors, diagnostic algorithms, and different approaches in antifungal therapy for invasive aspergillosis in non-neutropenic patients are reviewed.
Lingua originaleEnglish
pagine (da-a)458-458
Numero di pagine1
RivistaCritical Care
Volume18
DOI
Stato di pubblicazionePubblicato - 2014

Keywords

  • Adrenal Cortex Hormones
  • Antifungal Agents
  • Aspergillosis
  • Communicable Diseases, Emerging
  • Critical Illness
  • Humans
  • Immunocompromised Host
  • Incidence
  • Intensive Care Units
  • Opportunistic Infections
  • Prevalence
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive
  • Risk Factors

Fingerprint Entra nei temi di ricerca di 'How to manage aspergillosis in non-neutropenic intensive care unit patients'. Insieme formano una fingerprint unica.

Cita questo